Research & Development



  當甦稚出現在門口的時候,那些原本一聲都不敢發出來的婆子們,頓時就爆發出一聲慘叫——“細君救我!”   劉徹停止了大笑,瞅著雲瑯道︰“你覺得朝中無奸佞麼?”超碰免费视频公开观看   掌櫃的嘿嘿笑道︰“家主是一個讀書人,少主人是一個笨蛋,夏侯氏多讀書人,也多笨蛋,只有公子成為夏侯氏姑爺了,我們這些人才有些盼頭。”超碰视频夫妻在线播放   可是呢,手斷了,痛徹心扉嗎,總要找一些泄憤的對象吧? 色和尚在线视频久   霍光笑道︰“偷我師傅的。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo